Publications
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.. J Alzheimers Dis. 52(1):51-64.
.
2016. Defeating Alzheimer's disease and other dementias: a priority for European science and society.. Lancet Neurol. 15(5):455-532.
.
2016. Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
.
2016. Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 12(1):60-4.
.
2016. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.. Int Psychogeriatr. 27(1):7-17.
.
2015. .
2015. .
2015. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.. Clin Interv Aging. 9:2065-77.
.
2014. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.. J Intern Med. 275(3):304-16.
.
2014. A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study.. Acta Psychiatr Scand. 129(1):63-72.
.
2014. Mild cognitive impairment and progression to dementia: new findings.. Neurology. 82(4):e34-5.
.
2014. Plasma proteins predict conversion to dementia from prodromal disease.. Alzheimers Dement. 10(6):799-807.e2.
.
2014. Predicting decline in mild cognitive impairment: a prospective cognitive study.. Neuropsychology. 28(4):643-52.
.
2014. Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.. Amyloid. 21(3):143-8.
.
2014. What should we do if we were wrong and Alzheimer was right? Int Psychogeriatr. 26(1):3-6.
.
2014.